Joint Determinants of Bone Density and CVD Calcification
NCT00037414
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT Number: NCT00005408
To reanalyze data on risk factors for cardiovascular disease (CVD) including total cholesterol and high density lipoprotein (HDL) cholesterol for the subjects in the first, second, and third exams of the NHLBI Twin Study.
Looking for future studies?
Notify MeUp to 100 year
Male
Observational
BACKGROUND:
The results of these longitudinal analyses yielded new insights on genetic effects affecting CVD risk factors during the aging process.
DESIGN NARRATIVE:
The analyses utilized maximum likelihood estimators of genetic variance which were asymptotically more efficient than the method-of-moments estimators used in previous analyses. The models used incorporated terms to partition the variance in a trait from twin data into either i) additive genetic variance and unshared environmental variance (the AE model), ii) additive genetic variance, dominance genetic variance, and unshared environmental variance (the ADE model), or iii) additive genetic variance, shared environmental variance, and unshared environmental variance (the ACE model). The AE, ADE, and ACE models were fitted separately to data from each of the three exams to obtain a cross-sectional analysis. The investigators also extended these models for use with longitudinal data by incorporating terms to represent the covariance of variance components from different exams.
Two important additional objectives of this study were i) to introduce resistant estimation techniques in twin modeling, which trimmed the effect of outlier data points smoothly, and ii) to carefully study the performance of maximum likelihood and method-of-moments estimators when assumptions of the twin model were violated. The results of these parts of the study should yield a more complete understanding of the relative merits and limitations of twin modeling procedures.
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
No eligibility criteria
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00037414
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00005393
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00005214
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT00064506
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details